Evidence map›Paper›PMID 41641004›Full record

SynthesisFrontiers in research metrics and analytics2025

Artificial intelligence in the retraction spotlight: trends, causes and consequences of withdrawn AI literature through a systematic bibliometric review.

Kannan Sridharan, Gowri Sivaramakrishnan

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in research metrics and analytics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kannan SridharanDepartment of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama, Bahrain.
Gowri SivaramakrishnanBahrain Defence Force Royal Medical Services, Riffa, Bahrain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The rapid integration of artificial intelligence (AI) in scientific research has introduced new challenges to academic integrity, with increasing concerns about AI-related article retractions. This study conducts a comprehensive bibliometric analysis of retracted AI-related articles to characterize their prevalence, causes, and impact on scholarly communication. Methods: A systematic search was performed in Scopus using the terms "Artificial Intelligence" OR "AI" AND "retract Results: From an initial yield of 1,152 articles, 335 retracted publications met inclusion criteria after duplicate removal and screening. The analysis revealed that 46.3% (155/335) of retractions occurred in 2023, with a median retraction time of 550 days post-publication. Engineering accounted for 30.4% (102/335) of retractions, while 72.2% (243/335) originated from China. Compromised peer review was the most common retraction reason, though 37.9% (127/335) lacked specific justification. Strikingly, 51.1% (172/335) of retracted articles-maintained field citation ratios >1, indicating persistent scholarly influence. Articles in special issues showed significantly faster submission-to-acceptance timelines ( Discussion: This study highlights systemic vulnerabilities in AI-related research publication, particularly concerning peer review integrity and prolonged retraction timelines. The continued citation of retracted articles underscores the need for improved retraction alert systems. These findings call for stronger ethical guidelines and technological safeguards to maintain trust in AI-driven scholarly outputs.

Indexed as

AIartificial intelligencepublication ethicsretractionsscientific misconduct

Identifiers

PMID41641004
PMCPMC12864414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.